Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

20.44USD
12 Dec 2018
Change (% chg)

$0.62 (+3.13%)
Prev Close
$19.82
Open
$20.00
Day's High
$21.05
Day's Low
$19.50
Volume
9,748
Avg. Vol
12,333
52-wk High
$34.10
52-wk Low
$11.45

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $12.90
Shares Outstanding(Mil.): 0.74
Dividend: --
Yield (%): --

Financials

  ACER.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -7.59 -- --
ROI: -141.39 9.01 14.96
ROE: -141.39 10.15 16.52

Earnings vs. Estimates